Ifp Advisors, Inc Nektar Therapeutics Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$2.03 - $4.28 $26 - $55	-13 Reduced 5.2%	237 $2,000
Q2 2022 Sep 06, 2022	BUY	$3.17 - $6.17 $792 - $1,542	250 New	250 $3,000
Q2 2022 Aug 12, 2022	SELL	$3.17 - $6.17 $792 - $1,542	-250 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$4.16 - $13.72 $416 - $1,372	100 Added 66.67%	250 $1,000
Q1 2022 Aug 08, 2022	BUY	$4.16 - $13.72 $624 - $2,058	150 New	150 $0
Q4 2021 Jan 12, 2022	SELL	$10.83 - $18.41 $379 - $644	-35 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$16.86 - $23.44 $488 - $679	-29 Reduced 45.31%	35 $1,000
Q1 2020 May 12, 2020	BUY	$14.47 - $27.96 $926 - $1,789	64 New	64 $2,000
Q4 2019 Jan 17, 2020	BUY	$15.87 - $23.12 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	SELL	$16.91 - $36.27 $10,467 - $22,451	-619 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$31.58 - $46.35 $15,095 - $22,155	-478 Reduced 43.57%	619 $21,000
Q4 2018 Jan 23, 2019	SELL	$30.43 - $56.65 $51,061 - $95,058	-1,678 Reduced 60.47%	1,097 $36,000
Q3 2018 Oct 25, 2018	BUY	$46.46 - $68.49 $52,081 - $76,777	1,121 Added 67.78%	2,775 $0
Q2 2018 Aug 07, 2018	SELL	$46.25 - $104.45 $1,850 - $4,178	-40 Reduced 2.36%	1,654 $0
Q1 2018 Jun 03, 2019	SELL	$57.4 - $108.44 $10,159 - $19,193	-177 Reduced 9.46%	1,694 $101,000
Q1 2018 May 09, 2018	BUY	$57.4 - $108.44 $10,159 - $19,193	177 Added 10.45%	1,871 $0
Q4 2017 Jan 24, 2018	BUY	$23.02 - $60.5 $184 - $484	8 Added 0.47%	1,694 $0
Q2 2017 Jun 03, 2019	SELL	N/A	-900 Reduced 34.8%	1,686 $33,000
Q1 2017 Jun 03, 2019	BUY	N/A	921 Added 55.32%	2,586 $61,000
Q4 2016 Jun 03, 2019	BUY	N/A	165 Added 11.0%	1,665 $20,000
Q2 2016 Jun 03, 2019	BUY	N/A	881 Added 142.33%	1,500 $21,000
Q1 2016 Jun 03, 2019	BUY	N/A	619	619 $21,000

Others Institutions Holding NKTR

# of Institutions

140

Shares Held

135M

Call Options Held

32.8K

Put Options Held

55.5K

Deep Track Capital, LP Greenwich, CT

17.9M
Shares

$23.2 Million
0.73% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$19.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13M
Shares

$16.9 Million
0.0% of portfolio
Samlyn Capital, LLC New York, NY

9.46M
Shares

$12.3 Million
0.21% of portfolio
Eventide Asset Management, LLC Boston, MA

7.53M
Shares

$9.79 Million
0.16% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account